U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 2

1.
Figure 2

Figure 2. From: Targeting BRAF for patients with melanoma.

Common types of BRAF mutations in melanoma ().

H-T Arkenau, et al. Br J Cancer. 2011 Feb 1;104(3):392-398.
2.
Figure 1

Figure 1. From: Targeting BRAF for patients with melanoma.

The MAPK pathway activation in melanoma. Oncogenic NRAS, BRAF, GNAQ and CKIT signal through the MAPK pathway. Oncogenic NRAS also induces the phosphatidylinositol-3′ kinase (PI3K) cascade. MAPK signalling can lead to proliferation in transformed cells, but also induces a potent form of growth arrest, known as senescence in normal melanocytes. The approximate proportion of melanomas with mutations are shown. GPCR=G-protein coupled receptor.

H-T Arkenau, et al. Br J Cancer. 2011 Feb 1;104(3):392-398.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center